View clinical trials related to Pressure Ulcer.
Filter by:The purpose of this study is to analyse utility and compatibility of U-health solution service based on mobile for chronic wound management.
This trial is a prospective research to evaluate efficiency in U-health solution service based on Mobile for the chronic wound management.
The purpose of this study is to investigate if wound dressings are capable in reducing the effects of shear- force at the skin. With our own shear- force model we are able to apply 19 Newton shear- force combined with 9 newton pressure at the skin of the non- dominant forearm. After half an hour we measure IL-1alpha/ total protein- ratio, cutaneous blood flow (Laser doppler, Moor LDI) and the erythema index (DSMIIColormeter) which occurs as an effect of shear- force application at the skin. Then, we apply 19 Newton shear- force combined with 9 Newton pressure at the dominant fore-arm but this time we put a wound dressing between the skin and shear- force model. After half an hour we measure the IL-1alpha/total protein-ratio, cutaneous blood flow and the erythema index. This research consists of three research day, each day we are going to investigate a different wound dressing
Pressure ulcers are prevalent conditions that result in substantial financial costs to the healthcare system as well as significant distress to affected patients and their families. This study is a parallel two-group randomized controlled trial that aims to study how the use of a pressure sensing device with continuous visual feedback of pressure imaging may potentially decrease the interface pressure of patients who are at risk of pressure ulcers in an acute hospital setting.
The aim of this randomized controlled trial is to test the efficacy of preventive dressings for pressure ulcer prevention.
This study aims to evaluate the effectiveness of a PU prevention programme for for-profit private nursing homes
Evaluation of a wound care debridement product and a moisturizer on sacral pressure ulcer wounds
The primary objective of this post market clinical follow-up (PMCF) investigation is to evaluate performance and safety of Exufiber when used as intended in Stage II-IV pressure ulcers (PU).
The primary objective of these case series is to evaluate the safety and tolerability of the KLOX BioPhotonic System as adjunctive therapy to Standard Of Care (SOC) in patients with stage II or III pressure ulcers.
Our study aims to explore the effects of Adipose Derived Stem Cells (ASCs) on chronic wounds.